Connecting you to content on EBSCOhost

Works by Žuran, Ivan

Results: 3

1

Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial).

Published in:

Aging Male, 2020, v. 23, n. 5, p. 1442, doi. 10.1080/13685538.2020.1793132

By:

Groti Antonič, Kristina;
Antonič, Blaž;
Žuran, Ivan;
Pfeifer, Marija

Publication type:

Article

2

The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.

Published in:

Aging Male, 2018, v. 21, n. 3, p. 158, doi. 10.1080/13685538.2018.1468429

By:

Groti, Kristina;
Žuran, Ivan;
Antonič, Blaž;
Foršnarič, Lidija;
Pfeifer, Marija

Publication type:

Article

3

The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus—ENDIS Study.

Published in:

Pharmaceutics, 2023, v. 15, n. 7, p. 1945, doi. 10.3390/pharmaceutics15071945

By:

Navodnik, Maja Preložnik;
Janež, Andrej;
Žuran, Ivan

Publication type:

Article